Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001062993-24-005762

Chief Commercial Ofc Imm Med sold 29,390 shares at an average $3.44 ($100,994)

  • Chief Commercial Ofc Imm Med acquired 132,979 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BENZENO SHARON · Chief Commercial Ofc Imm Med

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-03-04 Grant or award : show line 1 in the form +132,979 356,805 D
2024-03-05 Sale : show line 2 in the form −10,746 $3.43 $36,859 346,059 D
2024-03-05 Sale : show line 3 in the form −18,644 $3.44 $64,135 327,415 D
Open-market sales · 29,390 sh · avg $3.44 · $100,994

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-03-04 Grant or award : show line 4 in the form Stock Option (right to buy) +199,549 199,549 D
Loading xslF345X05/form4.xml…